Building optimal 3-drug combination chemotherapy regimens.
Conclusions: A model-based system approach to evaluating combinations of 3 agents shows promise to rapidly identify the most promising combinations that can then be trialed.
PMID: 32900682 [PubMed - as supplied by publisher]
Source: Antimicrobial Agents and Chemotherapy - Category: Microbiology Authors: Drusano GL, Neely MN, Kim S, Yamada WM, Schmidt S, Duncanson B, Nole J, Mtchedlidze N, Peloquin CA, Louie A Tags: Antimicrob Agents Chemother Source Type: research
More News: Antiviral Therapy | Avelox | Bedaquiline | Chemotherapy | Laboratory Medicine | Microbiology | Moxifloxacin | Study | Tuberculosis